Stay updated on Pembrolizumab for Intermediate Risk NMIBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6. This signals a minor maintenance update without changing study details or core content.
    Difference
    0.1%
    Check dated 2026-09-01T18:10:47.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A funding attribution line for 2016 U.S. NIH Grant/Contract was added under Other Study ID Numbers, providing the source of support for the study. This addition adds administrative funding context without altering trial design, endpoints, or eligibility.
    Difference
    0.1%
    Check dated 2026-08-25T19:33:59.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page footer's revision label was incremented from v3.6.4 to v3.6.5, indicating a small update to the page metadata.
    Difference
    0.1%
    Check dated 2026-08-11T14:59:34.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page's revision stamp was updated from v3.6.3 to v3.6.4, replacing the previous revision with a newer version.
    Difference
    0.1%
    Check dated 2026-07-28T04:57:48.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.6.3, and older revision text along with links such as 'Bladder cancer' and 'MedlinePlus Genetics' were removed.
    Difference
    0.2%
    Check dated 2026-07-06T15:52:11.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0. This reflects a minor version update to the page template.
    Difference
    0.1%
    Check dated 2026-06-29T08:42:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Intermediate Risk NMIBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page.